• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺乳头状癌实性变体:发病率、临床病理特征、分子分析及生物学行为

Solid variant of papillary thyroid carcinoma: incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior.

作者信息

Nikiforov Y E, Erickson L A, Nikiforova M N, Caudill C M, Lloyd R V

机构信息

Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, Ohio 45267-0529, USA.

出版信息

Am J Surg Pathol. 2001 Dec;25(12):1478-84. doi: 10.1097/00000478-200112000-00002.

DOI:10.1097/00000478-200112000-00002
PMID:11717536
Abstract

Solid variant is a rare and poorly characterized variant of papillary thyroid carcinoma. In this study we analyzed 20 primary cases of the solid variant of papillary carcinoma found in a series of 756 papillary carcinomas operated at the Mayo Clinic between 1962 and 1989. The criteria for classification included predominantly (>70%) solid growth pattern of primary tumor, retention of cytologic features typical of papillary carcinoma, and absence of tumor necrosis. For each case of the solid variant, a control case of classical papillary carcinoma matched by age, sex, tumor size, and length of follow-up was selected. The follow-up ranged from 6 to 32 years. Two patients with the solid variant of papillary carcinoma (10%) died from disease 7 and 10 years after initial surgery, while another two patients (10%) are alive with lung metastases. In contrast, the control group had no cases with distant metastases or death from disease. Molecular analyses showed a similar prevalence of RET /PTC rearrangements in both groups. In conclusion, the solid variant of papillary carcinoma is associated with a slightly higher frequency of distant metastases and less favorable prognosis than classical papillary carcinoma. However, it should be distinguished from poorly differentiated thyroid carcinoma, which has a reported lower survival rate compared with the solid variant of papillary carcinoma.

摘要

实性变体是一种罕见且特征不明的甲状腺乳头状癌变体。在本研究中,我们分析了1962年至1989年间在梅奥诊所接受手术的756例乳头状癌系列中发现的20例原发性乳头状癌实性变体病例。分类标准包括原发性肿瘤主要为(>70%)实性生长模式、保留乳头状癌典型的细胞学特征以及无肿瘤坏死。对于每例实性变体病例,选择了年龄、性别、肿瘤大小和随访时间相匹配的经典乳头状癌对照病例。随访时间为6至32年。两名乳头状癌实性变体患者(10%)在初次手术后7年和10年死于该疾病,而另外两名患者(10%)存活但有肺转移。相比之下,对照组没有远处转移或死于该疾病的病例。分子分析显示两组中RET/PTC重排的发生率相似。总之,乳头状癌实性变体与远处转移频率略高以及预后比经典乳头状癌差有关。然而,它应与低分化甲状腺癌相区分,据报道低分化甲状腺癌的生存率低于乳头状癌实性变体。

相似文献

1
Solid variant of papillary thyroid carcinoma: incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior.甲状腺乳头状癌实性变体:发病率、临床病理特征、分子分析及生物学行为
Am J Surg Pathol. 2001 Dec;25(12):1478-84. doi: 10.1097/00000478-200112000-00002.
2
Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.乳头状甲状腺癌:来自2个家族的6例病例,伴有淋巴细胞性甲状腺炎,存在RET/PTC重排。
Br J Cancer. 2001 Dec 14;85(12):1831-7. doi: 10.1054/bjoc.2001.2187.
3
RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.甲状腺结节中的RET/PTC重排:儿童和成人受照射与未受照射、恶性与良性甲状腺病变的研究
J Clin Endocrinol Metab. 2001 Jul;86(7):3211-6. doi: 10.1210/jcem.86.7.7678.
4
Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations.甲状腺乳头状癌滤泡变体的分子特征及临床病理特征。ras突变的异常高发生率。
Am J Clin Pathol. 2003 Jul;120(1):71-7. doi: 10.1309/ND8D-9LAJ-TRCT-G6QD.
5
RET/PTC activation in hyalinizing trabecular tumors of the thyroid.甲状腺透明变梁状肿瘤中的RET/PTC激活
Am J Surg Pathol. 2000 Dec;24(12):1615-21. doi: 10.1097/00000478-200012000-00004.
6
Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications.甲状腺乳头状癌弥漫性硬化变异型:主要基因改变及预后意义
Histopathology. 2016 Jul;69(1):45-53. doi: 10.1111/his.12902. Epub 2016 Jan 11.
7
Hyalinizing trabecular tumor of the thyroid: a variant of papillary carcinoma proved by molecular genetics.甲状腺透明变梁状肿瘤:分子遗传学证实的乳头状癌变异型
Am J Surg Pathol. 2000 Dec;24(12):1622-6. doi: 10.1097/00000478-200012000-00005.
8
Prevalence and distribution of ret/ptc 1, 2, and 3 in papillary thyroid carcinoma in New Caledonia and Australia.新喀里多尼亚和澳大利亚甲状腺乳头状癌中ret/ptc 1、2和3的患病率及分布情况
J Clin Endocrinol Metab. 2000 Aug;85(8):2733-9. doi: 10.1210/jcem.85.8.6722.
9
RET gene rearrangements (RET/PTC1 and RET/PTC3) in papillary thyroid carcinomas from an iodine-rich country (Japan).来自碘充足国家(日本)的甲状腺乳头状癌中的RET基因重排(RET/PTC1和RET/PTC3)
Cancer. 2005 Sep 1;104(5):943-51. doi: 10.1002/cncr.21270.
10
Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese.台湾华人散发性乳头状甲状腺癌中RET重排(RET/PTC1、RET/PTC2、RET/PTC3和ELKS-RET)的低发生率
Thyroid. 2005 Apr;15(4):326-35. doi: 10.1089/thy.2005.15.326.

引用本文的文献

1
The Initial Risk Stratification System for Differentiated Thyroid Cancer: Key Updates in the 2024 Korean Thyroid Association Guideline.分化型甲状腺癌的初始风险分层系统:2024年韩国甲状腺协会指南的关键更新
Endocrinol Metab (Seoul). 2025 Jun;40(3):357-384. doi: 10.3803/EnM.2025.2465. Epub 2025 Jun 24.
2
Prevalence of Differentiated High-Grade Thyroid Carcinoma Among Well-Differentiated Tumors: A Systematic Review and Meta-Analysis.分化型高级别甲状腺癌在分化型肿瘤中的患病率:一项系统评价和荟萃分析
Thyroid. 2024 Mar;34(3):314-323. doi: 10.1089/thy.2023.0350.
3
Case Report: Solid variant of papillary thyroid carcinoma in a young adult with Turner syndrome with chronic thyroiditis.
病例报告:一名患有特纳综合征并伴有慢性甲状腺炎的年轻成年人的甲状腺乳头状癌实性变体。
Front Oncol. 2023 Nov 9;13:1150002. doi: 10.3389/fonc.2023.1150002. eCollection 2023.
4
Genetic alterations landscape in paediatric thyroid tumours and/or differentiated thyroid cancer: Systematic review.儿童甲状腺肿瘤和/或分化型甲状腺癌中的遗传改变全景:系统综述。
Rev Endocr Metab Disord. 2024 Feb;25(1):35-51. doi: 10.1007/s11154-023-09840-2. Epub 2023 Oct 24.
5
Solid/trabecular subtype of papillary thyroid carcinoma on cytology with focal differentiated high-grade thyroid carcinoma on histology: a cyto-histologic correlation.甲状腺乳头状癌细胞学上的实性/小梁状亚型伴组织学上局灶性分化型高级别甲状腺癌:细胞-组织学相关性
Ecancermedicalscience. 2023 Aug 10;17:1587. doi: 10.3332/ecancer.2023.1587. eCollection 2023.
6
Impact of the number of intermediate risk factors on outcome of papillary thyroid cancer.中间风险因素数量对甲状腺乳头状癌结局的影响。
Endocrine. 2024 Feb;83(2):442-448. doi: 10.1007/s12020-023-03496-3. Epub 2023 Sep 12.
7
Looking for RET alterations in thyroid cancer: clinical relevance, methodology and timing.寻找甲状腺癌中的 RET 改变:临床意义、方法和时机。
Endocrine. 2023 Aug;81(2):206-215. doi: 10.1007/s12020-023-03368-w. Epub 2023 May 17.
8
Molecular and clinical features of papillary thyroid cancer in adult patients with a non-classical phenotype.成人非典型表型甲状腺乳头状癌的分子和临床特征。
Front Endocrinol (Lausanne). 2023 Apr 12;14:1138100. doi: 10.3389/fendo.2023.1138100. eCollection 2023.
9
Histological Variants of Papillary Thyroid Cancer in Relation to Clinical and Morphological Parameters and Prognosis.甲状腺乳头状癌的组织学亚型与临床和形态学参数及预后的关系。
Bull Exp Biol Med. 2023 Mar;174(5):647-652. doi: 10.1007/s10517-023-05762-w. Epub 2023 Apr 12.
10
Research productivity in the genetics of papillary thyroid carcinoma (1991-2020): a bibliometric analysis.《1991-2020 年甲状腺乳头癌遗传学研究成果:文献计量分析》
Acta Biomed. 2022 Jul 1;93(3):e2022086. doi: 10.23750/abm.v93i3.12576.